“Sirtex Medical Inc., a subsidiary of Sirtex Medical Limited (ASX:SRX), is a leading manufacturer of targeted, innovative liver cancer therapies. Sirtex produces SIR-Spheres® microspheres, the only fully FDA-approved microsphere radiation therapy for the treatment of colorectal liver metastases. Sirtex’s U.S. headquarters are located in Woburn, Mass., and product for the U.S. market is produced at the company’s manufacturing facilities in Wilmington, Mass.